MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Prepaid expenses andother current assets-$129K (-188.36%↓ Y/Y)Accrued liabilities$128K (3.23%↑ Y/Y)Impairment of intangibleassets$111K Non-cash operating leaseexpense$86K (-42.67%↓ Y/Y)Stock-based compensation$59K (-63.35%↓ Y/Y)Inventories-$43K (-109.15%↓ Y/Y)Interest expense onrelated party note...$33K (-56.00%↓ Y/Y)Depreciation andamortization$27K (-75.23%↓ Y/Y)Change in inventoryreserve$15K (-72.73%↓ Y/Y)Net cash provided by(used in) operating...$167K (328.77%↑ Y/Y)Canceled cashflow$464K Net increase(decrease) in cash$156K (150.32%↑ Y/Y)Canceled cashflow$11K Accounts receivable$168K (290.70%↑ Y/Y)Accounts payable-$127K (-160.19%↓ Y/Y)Operating leaseliabilities-$98K (43.02%↑ Y/Y)Net loss-$71K (44.09%↑ Y/Y)Net cash used ininvesting activities-$11K (70.27%↑ Y/Y)Purchases of property andequipment$7K (-81.08%↓ Y/Y)Payments for patentlicenses$4K
Cash Flow

International Stem Cell CORP (ISCO)

International Stem Cell CORP (ISCO)

source: myfinsight.com